-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Ngm Biopharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2017 to Q4 2023.
- Ngm Biopharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending 31 Dec 2023 was -$27.7M, a 24.1% increase year-over-year.
- Ngm Biopharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending 31 Dec 2023 was -$142M, a 12.5% increase year-over-year.
- Ngm Biopharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$142M, a 12.5% increase from 2022.
- Ngm Biopharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$163M, a 35.2% decline from 2021.
- Ngm Biopharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$120M, a 17.4% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)